- Report
- April 2023
- 140 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- July 2024
- 158 Pages
Global
From €3777EUR$4,250USD£3,270GBP
- Report
- July 2024
- 153 Pages
Global
From €3777EUR$4,250USD£3,270GBP
- Report
- April 2022
- 241 Pages
Global
From €3200EUR$3,600USD£2,770GBP
- Report
- September 2023
- 31 Pages
North America
From €3551EUR$3,995USD£3,074GBP
- Report
- September 2023
- 39 Pages
Europe
From €3551EUR$3,995USD£3,074GBP
- Report
- September 2023
- 39 Pages
Asia Pacific
From €3551EUR$3,995USD£3,074GBP
- Report
- August 2023
- 17 Pages
India
From €2662EUR$2,995USD£2,305GBP
- Report
- August 2023
- 17 Pages
Germany
From €2662EUR$2,995USD£2,305GBP
- Report
- August 2023
- 17 Pages
Canada
From €2662EUR$2,995USD£2,305GBP
- Report
- August 2023
- 17 Pages
Australia
From €2662EUR$2,995USD£2,305GBP
- Report
- November 2021
- 51 Pages
Global
From €2222EUR$2,500USD£1,924GBP
- Report
- June 2025
- 221 Pages
Canada
From €5328EUR$5,995USD£4,613GBP
- Report
- June 2025
- 234 Pages
Australia
From €5328EUR$5,995USD£4,613GBP
- Report
- June 2025
- 207 Pages
India
From €5328EUR$5,995USD£4,613GBP
- Report
- June 2025
- 215 Pages
Germany
From €5328EUR$5,995USD£4,613GBP
- Report
- March 2025
- 51 Pages
South Korea
From €4439EUR$4,995USD£3,844GBP
- Report
- March 2025
- 51 Pages
India
From €4439EUR$4,995USD£3,844GBP
- Report
- March 2025
- 53 Pages
China
From €4439EUR$4,995USD£3,844GBP
- Report
- March 2025
- 53 Pages
Australia
From €4439EUR$4,995USD£3,844GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more